Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Genomic and molecular switching in relapsed acute promyelocytic leukemia

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Grimwade D . The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease. Br J Haematol 1999; 106: 591–613.

    Article  CAS  PubMed  Google Scholar 

  2. Gallagher RE, Li YP, Rao S, Paietta E, Andersen J, Etkind P et al. Characterization of acute promyelocytic leukemia cases with PML-RAR alpha break/fusion sites in PML exon 6: identification of a subgroup with decreased in vitro responsiveness to all-trans retinoic acid. Blood 1995; 86: 1540–1547.

    CAS  PubMed  Google Scholar 

  3. Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D et al. Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia. EMBO J 1992; 11: 1397–1407.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C et al. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 1997; 90: 1014–1021.

    CAS  PubMed  Google Scholar 

  5. Miyazaki K, Kikukawa M, Kiuchi A, Shin K, Iwamoto T, Ohyashiki K . Complex translocations derived stepwise from standard t(15;17) in a patient with variant acute promyelocytic leukemia. Cancer Genet Cytogenet 2007; 176: 127–130.

    Article  CAS  PubMed  Google Scholar 

  6. Xu L, Zhao WL, Xiong SM, Su XY, Zhao M, Wang C et al. Molecular cytogenetic characterization and clinical relevance of additional, complex and/or variant chromosome abnormalities in acute promyelocytic leukemia. Leukemia 2001; 15: 1359–1368.

    Article  CAS  PubMed  Google Scholar 

  7. Jensen K, Shiels C, Freemont PS . PML protein isoforms and the RBCC/TRIM motif. Oncogene 2001; 20: 7223–7233.

    CAS  PubMed  Google Scholar 

  8. Cloos J, Goemans BF, Hess CJ, van Oostveen JW, Waisfisz Q, Corthals S et al. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples. Leukemia 2006; 20: 1217–1220.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Ms MVC Pragnell, BA, for language revision of the manuscript. The financial support of Associazione Italiana contro le Leucemie (AIL)-BARI is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F Albano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Albano, F., Pannunzio, A., Anelli, L. et al. Genomic and molecular switching in relapsed acute promyelocytic leukemia. Leukemia 22, 1469–1472 (2008). https://doi.org/10.1038/sj.leu.2405103

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2405103

Search

Quick links